[go: up one dir, main page]

DK0771213T3 - Haemophilus influenza adhærens- og penetrationsproteiner - Google Patents

Haemophilus influenza adhærens- og penetrationsproteiner

Info

Publication number
DK0771213T3
DK0771213T3 DK95930245T DK95930245T DK0771213T3 DK 0771213 T3 DK0771213 T3 DK 0771213T3 DK 95930245 T DK95930245 T DK 95930245T DK 95930245 T DK95930245 T DK 95930245T DK 0771213 T3 DK0771213 T3 DK 0771213T3
Authority
DK
Denmark
Prior art keywords
adherence
haemophilus influenza
penetration proteins
penetration
proteins
Prior art date
Application number
DK95930245T
Other languages
English (en)
Inventor
Stanley Falkow
Geme Joseph W St Iii
Original Assignee
Univ Washington
Univ Leland Stanford Junior
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Washington, Univ Leland Stanford Junior filed Critical Univ Washington
Application granted granted Critical
Publication of DK0771213T3 publication Critical patent/DK0771213T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1242—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK95930245T 1994-08-25 1995-08-16 Haemophilus influenza adhærens- og penetrationsproteiner DK0771213T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/296,791 US6245337B1 (en) 1994-08-25 1994-08-25 Haemophilus adherence and penetration proteins
PCT/US1995/010661 WO1996005858A1 (en) 1994-08-25 1995-08-16 Haemophilus adherence and penetration proteins

Publications (1)

Publication Number Publication Date
DK0771213T3 true DK0771213T3 (da) 2007-05-14

Family

ID=23143573

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95930245T DK0771213T3 (da) 1994-08-25 1995-08-16 Haemophilus influenza adhærens- og penetrationsproteiner

Country Status (14)

Country Link
US (3) US6245337B1 (da)
EP (1) EP0771213B1 (da)
JP (1) JPH10507907A (da)
KR (1) KR100510608B1 (da)
AT (1) ATE350055T1 (da)
AU (1) AU704174B2 (da)
CA (1) CA2197562A1 (da)
DE (1) DE69535358T2 (da)
DK (1) DK0771213T3 (da)
ES (1) ES2278381T3 (da)
MX (1) MX9701404A (da)
NZ (1) NZ292019A (da)
PT (1) PT771213E (da)
WO (1) WO1996005858A1 (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6146886A (en) * 1994-08-19 2000-11-14 Ribozyme Pharmaceuticals, Inc. RNA polymerase III-based expression of therapeutic RNAs
US6676948B2 (en) * 1994-08-25 2004-01-13 Washington University Haemophilus adherence and penetration proteins
US6245337B1 (en) * 1994-08-25 2001-06-12 Washington University Haemophilus adherence and penetration proteins
US6914131B1 (en) 1998-10-09 2005-07-05 Chiron S.R.L. Neisserial antigens
GB9808866D0 (en) * 1998-04-24 1998-06-24 Smithkline Beecham Biolog Novel compounds
GB9810276D0 (en) * 1998-05-13 1998-07-15 Smithkline Beecham Biolog Novel compounds
GB9911683D0 (en) * 1999-05-19 1999-07-21 Chiron Spa Antigenic peptides
US7384640B1 (en) * 1999-09-30 2008-06-10 Wyeth Holdings Corporation Mutant cholera holotoxin as an adjuvant
CN100339482C (zh) 2000-02-28 2007-09-26 启龙股份公司 奈瑟球菌蛋白质的杂交表达
JP2005508143A (ja) 2001-06-07 2005-03-31 ワイス・ホールデイングス・コーポレーシヨン アジュバントとしてのコレラホロトキシンの突然変異形
ATE451386T1 (de) * 2001-06-07 2009-12-15 Wyeth Corp Mutantenformen von cholera holotoxin als adjuvans
JP2005517024A (ja) 2002-02-07 2005-06-09 イッサム リサーチ ディベロプメント カンパニー オブ ザ ヘブリュー ユニバーシティ オブ エルサレム 生物学的障壁を横切る透過を促進し得るアミノ酸配列
AU2003219832A1 (en) * 2002-02-22 2003-09-09 Washington University Haemophilus adherence and penetration proteins
EP1720997A1 (en) * 2004-03-02 2006-11-15 Binax, Inc. Methods to make and use antibodies of improved cross-reactivity
GB0410866D0 (en) * 2004-05-14 2004-06-16 Chiron Srl Haemophilius influenzae
US7709001B2 (en) 2005-04-08 2010-05-04 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
CN113198013B (zh) 2005-04-08 2024-02-20 惠氏有限责任公司 多价肺炎球菌多糖－蛋白质缀合物组合物
AU2009294321B2 (en) 2008-09-17 2014-02-13 Hunter Immunology Pty Ltd Non-typeable Haemophilus influenzae vaccines and their uses

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK130889A (da) * 1989-03-17 1990-09-18 Mogens Kilian Immunoglobulin a1-proteaser (iga1-proteaser), fremgangsmaade til genteknologisk fremstilling af saadanne enzymer samt vaccine indeholdende enzymerne og fragmenter deraf til immunisering mod bakteriel meningitis og andre sygdomme fremkaldt af iga1-protease-producerende bakterier
GB9205704D0 (en) * 1992-03-16 1992-04-29 Connaught Lab High molecular weight membrane proteins of non-typeable haemophilus
US6245337B1 (en) 1994-08-25 2001-06-12 Washington University Haemophilus adherence and penetration proteins

Also Published As

Publication number Publication date
US20030009010A1 (en) 2003-01-09
CA2197562A1 (en) 1996-02-29
MX9701404A (es) 1997-09-30
ATE350055T1 (de) 2007-01-15
DE69535358D1 (de) 2007-02-15
US6642371B2 (en) 2003-11-04
EP0771213A1 (en) 1997-05-07
KR970705408A (ko) 1997-10-09
AU704174B2 (en) 1999-04-15
JPH10507907A (ja) 1998-08-04
EP0771213A4 (en) 2002-08-07
US20040063908A1 (en) 2004-04-01
NZ292019A (en) 1999-02-25
AU3370295A (en) 1996-03-14
ES2278381T3 (es) 2007-08-01
DE69535358T2 (de) 2008-01-31
US6815182B2 (en) 2004-11-09
PT771213E (pt) 2007-04-30
KR100510608B1 (ko) 2006-04-28
EP0771213B1 (en) 2007-01-03
US6245337B1 (en) 2001-06-12
WO1996005858A1 (en) 1996-02-29

Similar Documents

Publication Publication Date Title
DK0771213T3 (da) Haemophilus influenza adhærens- og penetrationsproteiner
ITTO950367A0 (it) Proteine di prrsv ricombinanti, corredi diagnostici e vaccini contenenti tali proteine di prrsv ricombinanti.
BR9810654B8 (pt) mÉtodo de preparaÇço de um polipeptÍdeo, molÉculas de anticorpo e composiÇço.
DK0527760T3 (da) Fremgangsmåder og præparater til vaccination mod HIV
NO20016243D0 (no) Anti-alfav-beta3-rekombinante humane antistoffer, nukleinsyrer som koder for de samme og fremgangsmåter foranvendelse
DE69534568D1 (de) Säugetier-telomerase
AU2001241405A1 (en) Nucleic acids, proteins, and antibodies
DK0729951T3 (da) Naphthylforbindelser, mellemprodukter, præparater og fremgangsmåder
WO1996027665A3 (en) Neuron-restrictive silencer factor proteins
DE69634077D1 (de) Haemophilus adhäsionsproteinen
AU8405798A (en) A swine hepatitis e virus and uses thereof
DE69811677D1 (de) Verfahren zur präparation von enantiomer-angereicherten, n-derivatisierten laktamen.
BR0303226A (pt) Proteìnas de aderência e penetração de haemophilus
AU2001229508A1 (en) Nucleic acids, proteins, and antibodies
DE3672591D1 (de) Enzymimmunoassaymethode fuer den hautwachstumsfaktor.
NZ333376A (en) Haemophilus adherence and penetration proteins and vaccines therefrom
FI950253L (fi) Fimbria-antigeenejä, -vasta-aineita, -osoitusmenetelmiä ja -rokotteita
AU2001230958A1 (en) Nucleic acids, proteins, and antibodies
AU2001236465A1 (en) Nucleic acids, proteins, and antibodies
AU2001252878A1 (en) Nucleic acids, proteins, and antibodies
AU2001241403A1 (en) Nucleic acids, proteins, and antibodies
AU2001236460A1 (en) Nucleic acids, proteins, and antibodies
AU2001236459A1 (en) Nucleic acids, proteins, and antibodies
AU2001239728A1 (en) Nucleic acids, proteins, and antibodies